Can a phone call replace the Doctor's office for cancer genetic testing?

NCT ID NCT07471958

Recruiting now Knowledge-focused Sponsor: Abramson Cancer Center at Penn Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether people are interested in using telehealth and digital tools for genetic counseling and testing for hereditary cancer. 360 adults who meet guidelines for genetic testing will receive counseling at home and may use optional digital tools. The goal is to see how many complete the process and how they feel about it.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: telehealth genetic counseling and digital tools
What this could lead to: If successful, this could show that remote genetic testing is a practical option, making it easier for more people to access cancer risk information.
What could go wrong: This is an early-stage study focused on patient interest and feasibility, not on health outcomes. It may not prove that telehealth improves cancer detection or survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Abramson Cancer Center at the University of Pennsylvania
RECRUITING

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.